On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
ThursdaySep 21, 2023 12:21 pm

QualityStocksNewsBreaks – RJD Green Inc. (RJDG) Eyes Filling Market Niche Between ‘Big Box’ Stores and Smaller Retail Distributors with Silex

RJD Green (OTC: RJDG), a holding company, manages assets in three diverse, high-growth industries in separate “recession-resistant” markets, including construction, digital healthcare services and environmental solutions. “RJDG formed its specialty construction division to focus on industrial contracting, building material products and construction services. The company’s first acquisition, Silex Interiors, is a manufacturer, distributor and installer of countertops, cabinets, and related bathroom and kitchen products with a large target market comprising commercial contractors, residential builders, new and renovation contractors, and retail customers. With the aim of filling a market niche between ‘big box’ stores and smaller retail distributors, RJDG plans to…

Continue Reading

WednesdaySep 20, 2023 3:44 pm

QualityStocksNewsBreaks – Eloro Resources Ltd. (TSX: ELO) (OTCQX: ELRRF) (FSE: P2QM) Poised Amidst Global Demand for Tin

Eloro Resources (TSX: ELO) (OTCQX: ELRRF) (FSE: P2QM), an exploration and mine development company with a portfolio of gold and base-metal properties in Bolivia, Peru and Quebec, is among those seeking to fill the incremental gap in the supply of tin. “Eloro Resources has recently carried out a number of metallurgy studies linked to its flagship Iska Iska deposit; recent tests have revealed its key deposit to contain two extensive areas of potential mineralization – split into areas focused around silver-tin and silver-zinc-lead, respectively… The miner may soon affirm its place as an integral member of tin’s global supply chain,”…

Continue Reading

WednesdaySep 20, 2023 11:52 am

QualityStocksNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Building Protection and Powerful IP Portfolio for Its Diabetes Gene Therapy Program

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing treatments for patients with cancer and diabetes, recently announced its entry into an exclusive license agreement related to a particular gene therapy for both type 1 and type 2 diabetes. “Specifically, the announcement involves a worldwide exclusive license to a patent application and related technology, and a worldwide non-exclusive license to use certain related know-how using the genes of the Pdx1 and MafA transcription factors controlled by a MafB promoter, as developed by the University of Pittsburgh. Genprex is developing technologies to administer disease-fighting genes that will provide…

Continue Reading

WednesdaySep 20, 2023 11:20 am

QualityStocksNewsBreaks – GolfLync Inc. Eyes Viral-Scale Growth Driven by Genuine Enthusiasm, User Engagement

GolfLync, the company behind the GolfLync app – a social network for matching golf games and players, recently announced growth of its platform to surpass 50,000 members across the United States. “The exponential growth is a testament to the platform’s ability to bring golfers together, fostering vibrant communities and connections that continue to flourish… The viral scale of GolfLync’s growth can be attributed to the genuine enthusiasm and engagement of its members. Tens of thousands of posts, photos, videos, and tee times have been shared, turning GolfLync into a dynamic hub of golfing activity. The ability to have dedicated posts,…

Continue Reading

FridaySep 15, 2023 2:58 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) New Subsidiary Maximizing Patented DehydraTECH(TM) in Various Markets

Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery platforms, recently announced the incorporation of a new wholly owned subsidiary under the name Lexaria Nutraceutical Corp. (“LEXX Nutra”). “LEXX Nutra will keep with Lexaria’s overall strategy of maximizing the company’s patented DehydraTECH(TM) technology in various markets. Lexaria has issued an exclusive, perpetual license to LEXX Nutra, allowing the use of DehydraTECH to create consumer packaged goods and/or intermediate ingredients composed of molecular compounds except those associated with nicotine or cannabis,” a recent article reads. “LEXX Nutra is also prohibited from using the licensing agreement for the manufacturing of…

Continue Reading

FridaySep 15, 2023 2:08 pm

QualityStocksNewsBreaks – Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) on Track to Create Independent CM Supply Chain

Ucore Rare Metals (TSX.V: UCU) (OTCQX: UURAF), a company engaged in the exploration for and separation and scalable production of rare earth elements (“REEs”) in Canada and the US, is moving to become a major leader in its sector. “Just recently, the company announced the closing of the first tranche of its previously announced private placement offering of units of the company, for aggregate gross proceeds of $4,409,500, in what is set to be a key catalyst in advancing its RapidSX(TM) REE commercial demonstration plant in Kingston, Ontario,” a recent article reads. “On June 6, Ucore announced that the U.S.…

Continue Reading

FridaySep 15, 2023 1:01 pm

QualityStocksNewsBreaks – Why Renovaro BioSciences Inc. (NASDAQ: RENB) Is ‘One to Watch’

Renovaro BioSciences (NASDAQ: RENB), (formerly Enochian BioSciences Inc.), is an advanced, pre-clinical biotechnology firm in cell, gene and immunotherapy. “Renovaro aims to unlock potentially long-term or life-long cancer remission in some of the deadliest cancers, as well as to potentially treat or cure serious infectious diseases… The oncology platform is now at the forefront of Renovaro’s development activities. While Renovaro’s current efforts focus primarily on pancreatic cancer, it plans to include other solid tumors with short life-expectancy in the first in human phase I/IIa studies that are on track to start by mid-2024,” reads a recent article. “Renovaro’s proprietary, novel…

Continue Reading

FridaySep 15, 2023 12:57 pm

QualityStocksNewsBreaks – Electronic Servitor Publication Network Inc. (XESP) Is Driving the ‘Future of Marketing’

Electronic Servitor Publication Network (OTC: XESP), a technology-oriented digital engagement and activation company, is pioneering the next step in the evolution of digital marketing with its Digital Engagement Engine(TM). “‘Our Digital Engagement Engine isn’t just another marketing tool. It’s a way to develop real connections with your target market. And it’s the future of marketing,’ explains the company. The Digital Engagement Engine is built on a robust stack of cutting-edge data analysis tools, smart technologies and microservices, which, combined, enable it to identify the narrowest of niches within a company’s target market, create content that meets customers’ exact needs, and…

Continue Reading

FridaySep 15, 2023 12:26 pm

QualityStocksNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Looks Forward to Acclaim-3 Trial on Heels of Receipt of FDA FTD and ODD Designations

Genprex (NASDAQ: GNPX) is a clinical-stage gene therapy company focused on developing life-changing treatments for patients with cancer and diabetes. The company recently announced that the United States Food and Drug Administration (“FDA”) had granted Orphan Drug Designation (“ODD”) to its lead drug candidate, REQORSA(R) Immunogene Therapy (quratusugene ozeplasmid), for the treatment of small cell lung cancer (“SCLC”). The receipt of the ODD followed the FDA’s granting of Fast Track Designation (“FTD”) for REQORSA Immunogene Therapy in combination with Tecentriq in patients with ES-SCLC who did not develop tumor progression after receiving Tecentriq and chemotherapy as initial standard treatment. “With…

Continue Reading

FridaySep 15, 2023 12:19 pm

QualityStocksNewsBreaks – Fintech Ecosystem Development Corp. (NASDAQ: FEXD) Tapping Emerging Technologies to Address Unmet Mobile Money Needs

Fintech Ecosystem Development Corp. (NASDAQ: FEXD) is working to develop a global financial technology ecosystem. “The company is keen on addressing unmet mobile money needs in developing and industrialized markets and making mobile transactions easier and more affordable. To turn its vision into a reality, FEXD is adopting emerging technologies like artificial intelligence (‘AI’),” a recent article reads. “Given the role AI has historically played in helping companies detect, measure and manage risk, it is still being called upon to deal with financial crime and cyber threats and detect fraud. In addition, and alongside these crucial applications of the technology,…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.


Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered